Bladder cancer decisions — 2023

The Board has determined that the Veteran's claimed conditions are not related to his service, and thus denied claims for COPD, lung cancer, CAD, colon cancer, bladder cancer, and diabetes mellitus. The cases have been remanded for further examination and opinion regarding these conditions.

The Board has reopened the Veteran's claims for service connection for bilateral foot disorders, breast cancer, bladder cancer, right arm disorder, and peripheral neuropathy of the lower extremities. These issues are being remanded for additional development.

The Board denied the Veteran's appeal as to his claims for service connection and TDIU due to a lack of timely Notice of Disagreement (NOD) filed within one year of the August 17, 2015 rating decision.

The Veteran's bladder cancer is being remanded for a VA examination to determine if it was caused by his service, including exposure to burn pits while serving in the Southwest Asia theater of operations.

The Veteran's bladder cancer is denied as there was no evidence of herbicide exposure during service and the condition did not have onset during active duty or be otherwise related to service.

The Veteran's bladder cancer and its residuals are denied compensation under 38 U.S.C. § 1151 because the evidence does not support a finding that VA care caused his disability.

The Board has remanded the cases for further development due to inadequate medical opinions regarding the relationship between the Veteran's cervical spine disability, bladder disability, and service.

The Board has remanded the claims for service connection due to issues with obtaining relevant federal records and additional medical opinions. The appeals are not about presumed exposure to herbicide agents.

The Veteran's claim for service connection for bladder cancer, linked to exposure at Camp Lejeune, is remanded due to incomplete verification of his presence at the camp during training periods.

The Veteran's claim for an earlier effective date for service connection of bladder cancer was denied as the applicable law only allows retroactive application to the effective date of the changed law, which is March 14, 2017.

The Veteran's cause of death is due to bladder cancer, which was presumed to be associated with herbicide agent exposure during service. The Board found that the Veteran was exposed to herbicide agents while stationed near the DMZ in South Korea and granted service connection for his cause of death.

The Veteran's bladder cancer is presumed to have been caused by exposure to herbicide agents, specifically Agent Orange, while serving in Korea during the Vietnam era.,The Veteran's neuropathy of the right and left lower extremities are considered secondary to his service-connected bladder cancer.

The Veteran's appeal for service connection for bladder cancer was dismissed because the Appellant, through her attorney, withdrew the appeal in March 2023.

The Board has remanded the Veteran's claims for service connection due to his exposure to herbicide agents, including Agent Orange. The claims are being reviewed again to determine if there is sufficient evidence of in-service exposure and causation.

The Veteran's service-connected disabilities required regular aid and attendance, leading to the grant of special monthly compensation (SMC) based on need for aid and attendance.

The Veteran's claims for service connection for hypertension, residuals of bladder cancer, and kidney condition are granted. Service connection is established based on herbicide exposure during service.

Your claim for service connection for bladder cancer has been granted, and the issue is now moot.

The Veteran's bladder cancer is denied as there is no evidence linking the condition to his service, including exposure to ionizing radiation. The Board found that the estimated exposure dosage was below the threshold for significant risk.

The Board has remanded the issues of service connection for bladder cancer, an initial compensable rating for status post right upper lobectomy, service connection for COPD, and an initial rating in excess of 10 percent for coronary artery disease. The decision also includes a matter regarding entitlement to a rating in excess of 10 percent for bilateral pes planus prior to March 11, 2016, and in excess of 30 percent thereafter, including the issue of TDIU.

The Board has remanded the case for further investigation and adjudication regarding service connection for cause of death due to exposure to hazardous contaminants other than radiation at Kirtland Air Force Base, and for a claim under 38 U.S.C. § 1151 related to negligence in performing an incomplete resection surgery.